Back to Search
Start Over
AbbVie announces new data from Phase 3 studies of RINVOQ
- Source :
- The Fly. October 11, 2023
- Publication Year :
- 2023
-
Abstract
- AbbVie announced new data analyses from the Measure Up 1, Measure Up 2 and AD Up Phase 3 studies that further demonstrated the long-term efficacy and safety profile of RINVOQ, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.768466479